Advertisement

Topics

STAT Plus: Dueling data: Amgen fires back over cost effectiveness for its cholesterol drug

15:39 EDT 23 Aug 2017 | STAT

On the defensive about the value of its pricey cholesterol medicine, Amgen (AMGN) released a new study that argues its treatment is cost effective at about $9,700 a year, which…

Original Article: STAT Plus: Dueling data: Amgen fires back over cost effectiveness for its cholesterol drug

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Dueling data: Amgen fires back over cost effectiveness for its cholesterol drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...